Stock Details
AMGN is Amgen Inc.'s stock. Stock exchange NasdaqGS (Currency USD). Average price in 50 days is 244.41$. Average daily volumn in 3 months 3.31M. Market cap 130.66B

Stock symbol : AMGN. Exchange : NasdaqGS. Currency : USD
Lastest price : 244.59$. Total volume : 1.30M. Market state REGULAR
Click reload if you want to check the lastest price on market!!!

Amgen Inc. (AMGN)
Last Price

Previous Close244.85
Day Range243.75-247.58
Bid244.55 x 2.2k
Ask244.66 x 800
Average Volume3.31M
Market Cap130.66B
52 Week Range198.64-258.45
Trailing P/E24.17
Foward P/E12.89
Dividend (Yield %)3.25%
Ex-Dividend Date2022-05-16

Financial Details

According to Amgen Inc.'s financial reports the company's revenue in 2021 were 25.98B an increase(0%) over the years 2020 revenue that were of 25.42B. In 2021 the company's total earnings were 5.89B while total earnings in 2020 were 7.26B(-28.57%).

Loading ...


Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-rel... ated events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behรงet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Market Cap:
Total Assets:
Total Cash:

News about "Amgen Inc."

Amgen Inc. (NASDAQ:AMGN) Shares Sold by Spire Wealth Management

Source from : Defense World - 15 hours ago

Spire Wealth Management decreased its stake in shares of Amgen Inc. (NASDAQ:AMGN โ€“ Get Rating) by 30.6% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional ...See details»


Wealthcare Advisory Partners LLC Has $1.94 Million Holdings in Amgen Inc. (NASDAQ:AMGN)

Source from : Defense World - 1 days ago

Wealthcare Advisory Partners LLC raised its position in Amgen Inc. (NASDAQ:AMGN โ€“ Get Rating) by 0.8% during the first quarter, Holdings reports. The institutional investor owned 8,012 ...See details»


Amgen Inc. (NASDAQ:AMGN) Shares Purchased by Creative Financial Designs Inc. ADV

Source from : ETF Daily News - 1 days ago

Creative Financial Designs Inc. ADV increased its holdings in shares of Amgen Inc. (NASDAQ:AMGN โ€“ Get Rating) by 6.2% in the first quarter, according to the company in its most recent filing with the ...See details»


Flagship Harbor Advisors LLC Sells 210 Shares of Amgen Inc. (NASDAQ:AMGN)

Source from : ETF Daily News - 2 days ago

Flagship Harbor Advisors LLC reduced its stake in Amgen Inc. (NASDAQ:AMGN โ€“ Get Rating) by 7.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and ...See details»

2 Stocks That Could Survive the Next Recession

Source from : Nasdaq - 1 days ago

The Motley Fool recommends Amgen. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of ...See details»


Biotech firm Amgen lays out plans for its Humiraโ€™s biosimilar

Source from : The Financial Express on - 5 days ago

Europe's first approved biosimilar came in, and after 15 more received approval. However, in the eight years after the first U.S. biosimilar launch (2015), 36 have been approved and 22 have launched, ...See details»

Amgen Inc Among Leading Companies in the Male Infertility Pipeline Products Market | Globaldata Plc

Source from : - 5 days ago

Male infertility is caused due to low sperm production, immobile sperm, or blockages that prevent the delivery of sperm. Symptoms include pain, swelling or a lump in the ...See details»


Friday's Top Analyst Upgrades and Downgrades: Amgen, CarMax, GE, Home Depot, Marathon Digital, MetLife, Palantir, Realty Income, WeWork and More

Source from : 24/7 Wall St - 4 days ago

Wall St. reviews dozens of analyst research reports each day of the week with a goal of finding new ideas for investors and traders alike. Some of these daily analyst calls cover stocks to buy. Other ...See details»

Amgen Inc. (AMGN) Management Presents at Goldman Sachs 43rd Annual Global Healthcare Conference

Source from : Seeking Alpha - 13 days ago

Goldman Sachs 43rd Annual Global Healthcare Conference June 15, 2022 4:40 PM ET Company Participants Peter Griffith - Executive Vice President, ...See details»

Did Mirati Therapeutics Just Leapfrog Amgen?

Source from : - 20 days ago

While there are multiple types of KRAS mutations, Amgen (AMGN) - Get Amgen Inc. Report made history in 2021 by earning the first approval for this high-value target that was once considered ...See details»

Amgen Drug Gets Second FDA Nod

Source from : sfvbj - 8 days ago

The U.S. Food and Drug Administration has approved Amgen Inc.โ€™s Riabni in combination with chemotherapy drug methotrexate for adults with moderate to severely active rheumatoid arthritis (RA) who have ...See details»


Cancer Monoclonal Antibodies Market Competitive Analysis Growth Opportunities Forecast Report 2022-2029

Source from : Daily Herald - 5 days ago

According to the research report published by the DataM Intelligence, the global Cancer Monoclonal Antibodies Market size is projected to reach USD billion by the end of 2029, wit ...See details»


Amgen Foundation Invests Additional $30M in LabXchange

Source from : sfvbj - 8 days ago

Learn about The Amgen Foundation investing further into online science education platform LabXchange with a $30 million donation.See details»


Friday's Top Analyst Upgrades and Downgrades: Amgen, AutoZone, Boeing, Dollar General, Etsy, FedEx, Unity Software, Warner Bros. Discovery and More

Source from : 24/7 Wall St - 11 days ago

Wall St. reviews dozens of analyst research reports each day of the week with a goal of finding fresh ideas for investors and traders alike. Some of these daily analyst calls cover stocks to buy.See details»